Stockreport

Intensity Therapeutics Strengthens IP Portfolio with Issuance of New Patent in the US [Yahoo! Finance]

Intensity Therapeutics, Inc.  (INTS) 
PDF SHELTON, Conn. March 24, 2026 /PRNewswire/ -- Intensity Therapeutics, Inc. , (Nasdaq: INTS) ("Intensity" or the "Company"), a late-stage clinical biotechnology company [Read more]